Abstract
Weight gain is a known risk factor for the development of type 2 diabetes and even modest weight reduction can reduce the risk of developing diabetes, so controlling body weight is an important public health goal in the fight against diabetes and its comorbidities. Weight reduction is also a cornerstone of diabetes management, improving glycaemic control and reducing other risk factors associated with this disease. Pharmacotherapies such as sibutramine contribute to the management of type 2 diabetes in overweight and obese patients.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Van Gaal, L., Peiffer, F. The importance of obesity in diabetes and its treatment with sibutramine. Int J Obes 25 (Suppl 4), S24–S28 (2001). https://doi.org/10.1038/sj.ijo.0801935
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.ijo.0801935
Keywords
This article is cited by
-
Sibutramine lost and found
Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity (2002)